CollPlant Biotechnologies Statistics
Total Valuation
CLGN has a market cap or net worth of $55.70 million. The enterprise value is $35.50 million.
| Market Cap | 55.70M |
| Enterprise Value | 35.50M |
Important Dates
The next estimated earnings date is Thursday, August 22, 2024, before market open.
| Earnings Date | Aug 22, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CLGN has 11.45 million shares outstanding.
| Shares Outstanding | 11.45M |
| Owned by Insiders (%) | 10.16% |
| Owned by Institutions (%) | 12.23% |
| Float | 7.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 15.55 |
| PS Ratio | 5.24 |
| Forward PS | 24.82 |
| PB Ratio | 2.28 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.15, with a Debt / Equity ratio of 0.12.
| Current Ratio | 7.15 |
| Quick Ratio | 6.89 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 16.21 |
Financial Efficiency
Return on equity (ROE) is -24.70% and return on invested capital (ROIC) is -30.30%.
| Return on Equity (ROE) | -24.70% |
| Return on Assets (ROA) | -20.90% |
| Return on Capital (ROIC) | -30.30% |
| Revenue Per Employee | $141,653 |
| Profits Per Employee | -$99,987 |
| Employee Count | 75 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 1.82 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.78% in the last 52 weeks. The beta is 0.41, so CLGN's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | -23.78% |
| 50-Day Moving Average | 5.46 |
| 200-Day Moving Average | 5.45 |
| Relative Strength Index (RSI) | 39.78 |
| Average Volume (20 Days) | 9,363 |
Short Selling Information
| Short Interest | 625 |
| Short Previous Month | 1,663 |
| Short % of Shares Out | 0.01% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.06 |
Income Statement
In the last 12 months, CLGN had revenue of $10.62 million and -$7.50 million in losses. Loss per share was -$0.68.
| Revenue | 10.62M |
| Gross Profit | 8.41M |
| Operating Income | -8.32M |
| Pretax Income | -7.50M |
| Net Income | -7.50M |
| EBITDA | -6.89M |
| EBIT | -7.99M |
| Loss Per Share | -$0.68 |
Balance Sheet
The company has $23.23 million in cash and $3.02 million in debt, giving a net cash position of $20.21 million or $1.76 per share.
| Cash & Cash Equivalents | 23.23M |
| Total Debt | 3.02M |
| Net Cash | 20.21M |
| Net Cash Per Share | $1.76 |
| Equity (Book Value) | 24.45M |
| Book Value Per Share | 2.13 |
| Working Capital | 21.05M |
Cash Flow
In the last 12 months, operating cash flow was -$2.57 million and capital expenditures -$823,000, giving a free cash flow of -$3.39 million.
| Operating Cash Flow | -2.57M |
| Capital Expenditures | -823,000 |
| Free Cash Flow | -3.39M |
| FCF Per Share | -$0.30 |
Margins
Gross margin is 79.19%, with operating and profit margins of -78.33% and -70.59%.
| Gross Margin | 79.19% |
| Operating Margin | -78.33% |
| Pretax Margin | -70.59% |
| Profit Margin | -70.59% |
| EBITDA Margin | -64.85% |
| EBIT Margin | -75.23% |
| FCF Margin | -31.90% |
Dividends & Yields
CLGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.62% |
| Shareholder Yield | -1.62% |
| Earnings Yield | -13.46% |
| FCF Yield | -6.08% |
Analyst Forecast
The average price target for CLGN is $11.00, which is 126.20% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.00 |
| Price Target Difference | 126.20% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 21, 2016. It was a reverse split with a ratio of 2:3.
| Last Split Date | Nov 21, 2016 |
| Split Type | Reverse |
| Split Ratio | 2:3 |
Scores
CLGN has an Altman Z-Score of 1.37 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.37 |
| Piotroski F-Score | 4 |